| Economic health care costs of blood culture contamination: a systematic review C Dempsey, E Skoglund, KL Muldrew, KW Garey American Journal of Infection Control 47 (8), 963-967, 2019 | 77 | 2019 |
| Peramivir: an intravenous neuraminidase inhibitor MM McLaughlin, EW Skoglund, MG Ison Expert opinion on pharmacotherapy 16 (12), 1889-1900, 2015 | 73 | 2015 |
| Estimated clinical and economic impact through use of a novel blood collection device to reduce blood culture contamination in the emergency department: a cost-benefit analysis E Skoglund, CJ Dempsey, H Chen, KW Garey Journal of clinical microbiology 57 (1), 10.1128/jcm. 01015-18, 2019 | 46 | 2019 |
| In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways E Skoglund, H Abodakpi, R Rios, L Diaz, E De La Cadena, AQ Dinh, ... Case Reports in Infectious Diseases 2018, 2018 | 27 | 2018 |
| Using the theory of planned behavior to evaluate factors that influence pharmd students’ intention to attend lectures E Skoglund, J Fernandez, JT Sherer, EA Coyle, KW Garey, ML Fleming, ... American journal of pharmaceutical education 84 (5), 7550, 2020 | 26 | 2020 |
| Drug shortages and patient safety: an overview of essential information for the infusion nurse MM McLaughlin, EW Skoglund Journal of Infusion Nursing 38 (3), 205-208, 2015 | 21 | 2015 |
| Projections for antiinfective drug shortages and time to actual resolution MM McLaughlin, Z Pentoney, E Skoglund, MH Scheetz American Journal of Health-System Pharmacy 71 (23), 2074-2078, 2014 | 16 | 2014 |
| Significant publications on infectious diseases pharmacotherapy in 2016 G Fong, EW Skoglund, K Phe, J Guastadisegni, KM Shea, PM McDaneld, ... Journal of Pharmacy Practice 31 (5), 469-480, 2018 | 12 | 2018 |
| Development of a pharmacy student research program at a large academic medical center MM McLaughlin, E Skoglund, S Bergman, MH Scheetz American Journal of Health-System Pharmacy 72 (21), 1885-1889, 2015 | 11 | 2015 |
| Significant publications on infectious diseases pharmacotherapy in 2017 EW Skoglund, KM Dotson, CJ Dempsey, CP Su, F Foolad, C Janak, ... Journal of Pharmacy Practice 32 (5), 534-545, 2019 | 10 | 2019 |
| Developing a method for reporting patient harm due to antimicrobial shortages MM McLaughlin, E Skoglund, Z Pentoney, MH Scheetz Infectious diseases and therapy 3, 349-355, 2014 | 10 | 2014 |
| In vivo resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa arising by AmpC-and non-AmpC-mediated pathways. Case Rep Infect Dis 2018: 9095203 E Skoglund, H Abodakpi, R Rios, L Diaz, E De La Cadena, AQ Dinh, ... | 9 | 2018 |
| Prediction of inventory sustainability during a drug shortage NJ Rhodes, EM Gilbert, E Skoglund, JS Esterly, MJ Postelnick, ... American Journal of Health-System Pharmacy 73 (14), 1094-1098, 2016 | 9 | 2016 |
| Ceftolozane/tazobactam activity against meropenem-non-susceptible Pseudomonas aeruginosa bloodstream infection isolates. E Skoglund, KR Ledesma, TM Lasco, VH Tam Journal of global antimicrobial resistance 11, 154-155, 2017 | 6 | 2017 |
| Microbiologic clearance following transition from standard infusion piperacillin-tazobactam to extended-infusion for persistent Gram-negative bacteremia and possible … C D'Agostino, NJ Rhodes, E Skoglund, JA Roberts, MH Scheetz Journal of Infection and Chemotherapy 21 (10), 742-746, 2015 | 4 | 2015 |
| Effect of elevated imipenem/cilastatin minimum inhibitory concentrations on patient outcomes in gram-negative bloodstream infections MM McLaughlin, C Miglis, E Skoglund, J Wagner, MR Advincula, ... Journal of Global Antimicrobial Resistance 13, 261-263, 2018 | 3 | 2018 |
| Specialized pharmacist roles and perspectives in the collaborative management of COVID-19 E Skoglund, J Ayoub, HM Nguyen Journal of Pharmacy Practice 35 (2), 244-247, 2022 | 2 | 2022 |
| Precepting strategies to develop trainee resilience and overcome unexpected challenges in experiential learning E Skoglund, J Ayoub, HM Nguyen American Journal of Health-System Pharmacy 80 (11), 699-702, 2023 | 1 | 2023 |
| Factors that Influence PharmD Students’ Intention to Attend Lectures Using the Theory of Planned Behavior E Skoglund, J Fernandez, JT Sherer, EA Coyle, KW Garey, ML Fleming, ... American Journal of Pharmaceutical Education, 2019 | 1 | 2019 |
| Ceftolozane/tazobactam resistance in Pseudomonas aeruginosa E Skoglund, H Abodakpi, L Diaz, R Rios, TT Tran, CA Arias, VH Tam INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 50, S39-S39, 2017 | 1 | 2017 |
